PortfoliosLab logo
AADI vs. CPRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AADI and CPRX is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

AADI vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aadi Bioscience, Inc. (AADI) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

AADI:

$94.89M

CPRX:

$2.85B

EPS

AADI:

-$2.36

CPRX:

$1.57

PS Ratio

AADI:

3.79

CPRX:

5.80

PB Ratio

AADI:

1.40

CPRX:

3.59

Total Revenue (TTM)

AADI:

$20.63M

CPRX:

$534.65M

Gross Profit (TTM)

AADI:

$18.26M

CPRX:

$441.72M

EBITDA (TTM)

AADI:

-$45.84M

CPRX:

$250.28M

Returns By Period


AADI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

CPRX

YTD

14.18%

1M

8.07%

6M

1.62%

1Y

49.50%

5Y*

40.48%

10Y*

21.86%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AADI vs. CPRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AADI
The Risk-Adjusted Performance Rank of AADI is 5151
Overall Rank
The Sharpe Ratio Rank of AADI is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of AADI is 5353
Sortino Ratio Rank
The Omega Ratio Rank of AADI is 5252
Omega Ratio Rank
The Calmar Ratio Rank of AADI is 5050
Calmar Ratio Rank
The Martin Ratio Rank of AADI is 4949
Martin Ratio Rank

CPRX
The Risk-Adjusted Performance Rank of CPRX is 9090
Overall Rank
The Sharpe Ratio Rank of CPRX is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 9090
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8686
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 9494
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AADI vs. CPRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aadi Bioscience, Inc. (AADI) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

AADI vs. CPRX - Dividend Comparison

Neither AADI nor CPRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AADI vs. CPRX - Drawdown Comparison


Loading data...

Volatility

AADI vs. CPRX - Volatility Comparison


Loading data...

Financials

AADI vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between Aadi Bioscience, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M20212022202320242025
7.24M
141.42M
(AADI) Total Revenue
(CPRX) Total Revenue
Values in USD except per share items